Oncofertility in clinical practice

American Journal of Hematology/ Oncology

Volumn 8, Issue 8, 2009, Pages

  Redig, Amanda J ^a   Woodruff, Teresa K ^a   Jeruss, Jacqueline S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL PRACTICE; CRYOPRESERVATION; FEMALE FERTILITY; FEMALE INFERTILITY; GONAD FUNCTION; HORMONAL REGULATION; HUMAN; MALE FERTILITY; MEDICAL DECISION MAKING; NONHUMAN; NOTE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; THERAPY DELAY; TREATMENT PLANNING;

EID: 73249126782     PISSN: 15429520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360:902-911.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
3. Gadducci A, Cosio S, Genazzani AR. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol. 2007;23:625-631.
4. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med. 2005;353:64-73.
5. Davis VJ. Female gamete preservation. Cancer. 2006;107: 1690-1694.
6. Backhus LE, Kondapalli LA, Chang RJ, et al. Oncofertility consortium consensus statement: guidelines for ovarian tissue cryopreservation. Cancer Treat Res. 2007;138:235-239.
7. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343:1086-1094.
8. Gradishar WJ, Hellmund R. A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy. Clin Breast Cancer. 2002;2:282-286.
9. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817-2826.
10. Agarwal SK, Chang RJ. Fertility management for women with cancer. Cancer Treat Res. 2007;138:15-27.
11. West ER, Zelinski MB, Kondapalli LA, et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer. 2009;53:289-295.
12. Falcone T, Attaran M, Bedaiwy MA, et al. Ovarian function preservation in the cancer patient. Fertil Steril. 2004;81:243-257.
13. Stachecki JJ, Cohen J. An overview of oocyte cryopreservation. Reprod Biomed Online. 2004;9:152-163.
14. Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100:465-469.
15. Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194.
16. Gupta PB, Kuperwasser C. Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol. 2006;102:71-78.
17. Xu M, Kreeger PK, Shea LD, et al. Tissue-engineered follicles produce live, fertile offspring. Tissue Eng. 2006;12:2739-2746.
18. Telfer EE, McLaughlin M, Ding C, et al. A two-step serumfree culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod. 2008;23:1151-1158.
19. Tempest HG, Ko E, Chan P, et al. Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patients. Hum Reprod. 2008;23: 251-258.
20. O'Flaherty C, Vaisheva F, Hales BF, et al. Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy. Hum Reprod. 2008;23:1044-1052.
21. Nalesnik JG, Sabanegh ES Jr, Eng TY, et al. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol. 2004;27:584-588.
22. Brannigan RE. Fertility preservation in adult male cancer patients. Cancer Treat Res. 2007;138:28-49.
23. Schmiegelow ML, Sommer P, Carlsen E, et al. Penile vibratory stimulation and electroejaculation before anticancer therapy in two pubertal boys. J Pediatr Hematol Oncol. 1998;20:429-430.